Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 494 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Clinical experience with exenatide in obese North Indian patients with type 2 diabetes mellitus

Bawa Tarunika, Dhingra Vibha, Malhotra Nidhi, Wasir Jasjeet S, Mithal Ambrish

Year : 2013| Volume: 17| Issue : 1 | Page no: 91-94

   This article has been cited by
1 Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force
Sanjay Kalra,Ashok Kumar Das,Rakesh Kumar Sahay,Manash Pratim Baruah,Mangesh Tiwaskar,Sambit Das,Sudip Chatterjee,Banshi Saboo,Ganapathi Bantwal,Saptarshi Bhattacharya,Gagan Priya,Manoj Chawla,Kiraninder Brar,Syed Abbas Raza,Azizul Hasan Aamir,Dina Shrestha,Noel Somasundaram,Prasad Katulanda,Faria Afsana,Shahjada Selim,Mohammad Wali Naseri,Ali Latheef,Manilka Sumanatilleke
Diabetes Therapy. 2019;
[Pubmed]  [Google Scholar] [DOI]
2 Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists
Qiuhe Ji
Clinical Therapeutics. 2017; 39(6): 1244
[Pubmed]  [Google Scholar] [DOI]
3 Efficacy and tolerability of GLP-1 agonists in patients with type 2 diabetes mellitus: an Indian perspective
Mala Dharmalingam
Therapeutic Advances in Endocrinology and Metabolism. 2014; 5(6): 159
[Pubmed]  [Google Scholar] [DOI]


Read this article